{
    "clinical_study": {
        "@rank": "132649", 
        "arm_group": {
            "arm_group_label": "Misoprostol + vasopressin, Vasopressin", 
            "arm_group_type": "Experimental", 
            "description": "Misoprostol 400ug given rectally one hour before surgery."
        }, 
        "brief_summary": {
            "textblock": "This study was done to determine if  the use of a combination of preoperative rectal\n      misoprostol 400\u00b5g used with intraoperative perivascular vasopressin is better than\n      perivascular vasopressin used alone to decrease bleeding at myomectomy."
        }, 
        "brief_title": "Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy", 
        "completion_date": {
            "#text": "April 2005", 
            "@type": "Actual"
        }, 
        "condition": "Hemorrhage", 
        "condition_browse": {
            "mesh_term": "Hemorrhage"
        }, 
        "detailed_description": {
            "textblock": "A myomectomy is a fertility sparing procedure in which fibroids are removed from the uterus.\n      This procedure can be associated with significant blood loss which can result in significant\n      morbidity and mortality.  The drug misoprostol which has been been use in the treatment of\n      postpartum hemorrhage was given to subset of patients who were scheduled to undergo elective\n      myomectomy at the University hospital of the West Indies and from the private practice of\n      the participating doctors who were invited to participate in the study. Patients were\n      randomized to receive or not to receive pre-operative rectal misoprostol 400\u00b5g,  60 minutes\n      before surgery. Twenty five patients received misoprostol and twenty patients did not."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with symptomatic fibroids who desire future fertility and or who wish to\n             maintain their uterus.\n\n        Exclusion Criteria:\n\n          -  patients who have had previous myomectomy or previous pelvic surgery.\n\n          -  patients who are severely anemic or who have significant medical conditions such as\n             cardiac or pulmonary disease.\n\n          -  patients who refuse to participate or give consent to the procedures. Patients with a\n             known allergy to any of the study drugs."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01700478", 
            "org_study_id": "MV-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Misoprostol + vasopressin, Vasopressin", 
                "description": "400ug of misoprostol is given per rectum,  one hour prior to surgery. Vasopressin is used at the time of surgery.", 
                "intervention_name": "Misoprostol + vasopressin", 
                "intervention_type": "Drug", 
                "other_name": "Cytotec"
            }, 
            {
                "arm_group_label": "Misoprostol + vasopressin, Vasopressin", 
                "description": "Vasopressin was used in all patients during surgery.", 
                "intervention_name": "Vasopressin", 
                "intervention_type": "Drug", 
                "other_name": "Anti-diuretic hormone"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vasopressins", 
                "Arginine Vasopressin", 
                "Misoprostol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Myomectomy", 
        "lastchanged_date": "February 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kingston", 
                    "country": "Jamaica"
                }, 
                "name": "University Hospital of the West Indies"
            }
        }, 
        "location_countries": {
            "country": "Jamaica"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Trial Comparing The Use Of Rectal Plus Perivascular Vasopressin With Perivascular Vasopressin Alone To Decrease Bleeding At The Time Of Myomectomy", 
        "overall_official": {
            "affiliation": "University Hospital of the West Indies", 
            "last_name": "Sharifa K Frederick, dM", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Jamaica: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Blood loss in millilitres", 
            "safety_issue": "No", 
            "time_frame": "At the time of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01700478"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital of the West Indies", 
            "investigator_full_name": "Dr Sharifa Frederick", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "A change in hemoglobin grams per decilitre", 
            "safety_issue": "No", 
            "time_frame": "At baseline and 24hours after surgery"
        }, 
        "source": "University Hospital of the West Indies", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital of the West Indies", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2005", 
        "study_design": "Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}